Use of remdesivir for COVID-19 pneumonia in patients with advanced kidney disease: A retrospective multicenter study

Use of remdesivir for COVID-19 pneumonia in patients with advanced kidney disease: A retrospective multicenter study

Background and objectives: Remdesivir, an antiviral drug routinely used in the treatment of COVID-19 has not yet received FDA approval for use in patients with advanced kidney disease defined as GFR < 30 mL/min/1.73 m2. There is concern that an excipient in Veklury (Gilead’s proprietary name for...

Full description

Bibliographic Details
Main Authors:	F. Stancampiano, N. Jhawar, W. Alsafi, J. Valery, D.M. Harris, P. Kempaiah, S. Shah, M.G. Heckman, H. Siddiqui, C.R. Libertin
Format:	Article
Language:	English
Published:	Elsevier 2022-11-01
Series:	Clinical Infection in Practice
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590170222000759

Similar Items

Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia
by: Judit Cacho, et al.
Published: (2022-05-01)

Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.
by: Simon B Gressens, et al.
Published: (2022-01-01)

Remdesivir in a pregnant patient with COVID-19 pneumonia
by: Ranadheer Dande, et al.
Published: (2021-01-01)

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia
by: Vasilis Petrakis, et al.
Published: (2022-09-01)

Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys
by: Lin Xu, et al.
Published: (2021-07-01)

Use of Remdesivir in children with COVID-19: report of an Italian multicenter study
by: Lorenza Romani, et al.
Published: (2024-02-01)

COVID-19 and kidney transplantation: the impact of remdesivir on renal function and outcome - a retrospective cohort study
by: Florin Elec, et al.
Published: (2022-05-01)

Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function.
by: Rituvanthikaa Seethapathy, et al.
Published: (2023-01-01)

Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State
by: Alessandro Libra, et al.
Published: (2023-10-01)

Remdesivir Alleviates Acute Kidney Injury by Inhibiting the Activation of NLRP3 Inflammasome
by: Liang Yin, et al.
Published: (2021-05-01)

Acute kidney injury in SARS-CoV2-related pneumonia ICU patients: a retrospective multicenter study
by: Guillaume Geri, et al.
Published: (2021-05-01)

Clinical use of remdesivir in COVID-19 treatment: a retrospective cohort study
by: Hong Tham Pham, et al.
Published: (2023-06-01)

Effect of Remdesivir on COVID-19 PCR Positivity and Cycle Threshold in Kidney Transplant Recipients
by: Ryan J. Winstead, et al.
Published: (2021-08-01)

Efficacy and Safety of Remdesivir in Hospitalized Pediatric COVID-19: A Retrospective Case-Controlled Study
by: Khalil A, et al.
Published: (2023-11-01)

A Retrospective Analysis of Gender-Based Difference in Adherence to Influenza Vaccination during the 2018-2019 Season
by: Andres Applewhite, et al.
Published: (2020-09-01)

Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19)
by: Jeremie Zerbit, et al.
Published: (2022-11-01)

Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia
by: Bhargavi Donepudi, et al.
Published: (2022-01-01)

Clinical course of patients with severe COVID-19 pneumonia treated with remdesivir: A real-life study.
by: Diana Tejada, et al.
Published: (2022-01-01)

Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report
by: José A Gonzales-Zamora, et al.
Published: (2020-08-01)

Use of tocilizumab, remdesivir, and high-dose methylprednisolone prevents intubation in an ESRD patient with COVID-19 pneumonia
by: Ramzan Judge, et al.
Published: (2022-01-01)

A Retrospective Evaluation of Combination Therapy of Methylprednisolone and Remdesivir for Severe COVID-19 Patients
by: Shruti Jain, et al.
Published: (2021-07-01)

Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database
by: Nayara Aparecida de Oliveira Silva, et al.
Published: (2021-11-01)

Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection
by: Damiana-Maria Vulturar, et al.
Published: (2022-11-01)

Severe atypical pneumonia in critically ill patients: a retrospective multicenter study
by: S. Valade, et al.
Published: (2018-08-01)

The journey of remdesivir: from Ebola to COVID-19
by: Joe Pardo, et al.
Published: (2020-05-01)

Chitosan-Based Nanocarriers for Delivery of Remdesivir
by: Viktoria Milkova, et al.
Published: (2023-08-01)

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events
by: John T. Sullivan
Published: (2022-04-01)

To Determine the Efficacy of Remdesivir in Covid-19
by: A. Hameed, et al.
Published: (2022-03-01)

Remdesivir Treatment in Moderately Ill COVID-19 Patients: A Retrospective Single Center Study
by: Vedrana Terkes, et al.
Published: (2022-08-01)

Clinical Outcomes of Remdesivir in Moderate and Severe Cases of COVID-19: A Retrospective Cohort Study
by: Ruth Priya Senthiappan, et al.
Published: (2023-01-01)

Remdesivir versus Standard of Care in Moderate to Severe COVID-19 Patients: A Retrospective Study
by: JM JEETENDRA KUMAR, et al.
Published: (2021-04-01)

Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19
by: Alireza FakhriRavari, et al.
Published: (2024-02-01)

Transient Lactic Acidosis and Elevation of Transaminases after the Introduction of Remdesivir in a Patient with Acute Kidney Injury
by: Elise André, et al.
Published: (2024-01-01)

Evolution of the Synthesis of Remdesivir. Classical Approaches and Most Recent Advances
by: Didier F. Vargas, et al.
Published: (2021-07-01)

Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis
by: Ryan Geffin MD, et al.
Published: (2023-09-01)

Clinical Characteristics of Macrolide-Refractory <i>Mycoplasma pneumoniae</i> Pneumonia in Korean Children: A Multicenter Retrospective Study
by: Yun Jung Choi, et al.
Published: (2022-01-01)

Transparency, health equity, and strategies in state-based protocols for remdesivir allocation and use
by: Zippora Kiptanui, et al.
Published: (2021-01-01)

Adverse effects of remdesivir for the treatment of acute COVID-19 in the pediatric population: a retrospective observational study
by: Abigail Schulz, et al.
Published: (2024-02-01)

Current and future use of remdesivir in patients with COVID-19
by: V. M. Tsvetov, et al.
Published: (2020-10-01)

That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
by: Matthew R. Davis, et al.
Published: (2020-07-01)